Success Metrics

Clinical Success Rate
90.0%

Based on 18 completed trials

Completion Rate
90%(18/20)
Active Trials
6(16%)
Results Posted
39%(7 trials)
Terminated
2(5%)

Phase Distribution

Ph phase_1
9
24%
Ph not_applicable
8
21%
Ph phase_4
8
21%
Ph phase_2
6
16%
Ph early_phase_1
2
5%
Ph phase_3
5
13%

Phase Distribution

11

Early Stage

6

Mid Stage

13

Late Stage

Phase Distribution38 total trials
Early Phase 1First-in-human
2(5.3%)
Phase 1Safety & dosage
9(23.7%)
Phase 2Efficacy & side effects
6(15.8%)
Phase 3Large-scale testing
5(13.2%)
Phase 4Post-market surveillance
8(21.1%)
N/ANon-phased studies
8(21.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

18 of 22 finished

Non-Completion Rate

18.2%

4 ended early

Currently Active

6

trials recruiting

Total Trials

38

all time

Status Distribution
Active(8)
Completed(18)
Terminated(4)
Other(8)

Detailed Status

Completed18
unknown8
Recruiting4
Terminated2
Not yet recruiting2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
38
Active
6
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (5.3%)
Phase 19 (23.7%)
Phase 26 (15.8%)
Phase 35 (13.2%)
Phase 48 (21.1%)
N/A8 (21.1%)

Trials by Status

terminated25%
recruiting411%
completed1847%
not_yet_recruiting25%
unknown821%
active_not_recruiting25%
withdrawn25%

Recent Activity

Clinical Trials (38)

Showing 20 of 38 trialsScroll for more
NCT07459166Phase 2

A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade

Not Yet Recruiting
NCT05612178Phase 1

A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy

Active Not Recruiting
NCT05856890Phase 1

HepB mAb19 in Individuals With Chronic Hepatitis B Infection

Recruiting
NCT06721494Phase 2

A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

Recruiting
NCT00636480Phase 3

Preoperative Skin Preparation Evaluation

Completed
NCT06316973Phase 1

A Clinical Study to Evaluate the Safety of CS-1103 in Healthy Participants

Completed
NCT06282965Phase 1

Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury

Recruiting
NCT04046900Phase 1

Vaginal Microbiota Transplant

Recruiting
NCT06194578Early Phase 1

A Study of Sterile Saline Infusion in Healthy Volunteers

Completed
NCT04079686Not Applicable

Single Dose Versus 24 Hours Antibiotic Prophylaxis in Reduction Mammaplasty

Completed
NCT05602493Phase 3

A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Efficacy and Safety of Topical Alendronic Acid on Alveolar Bone Remodeling After Tooth Extraction

Active Not Recruiting
NCT02712151Phase 3

Efficacy of Transversus Abdominis Plane Block for Laparoscopic Cholecystectomy

Withdrawn
NCT03184155Early Phase 1

Prevention of Coronary Microvascular Dysfunction Post-PCI by Intracoronary Nicardipine

Withdrawn
NCT05434260Not Applicable

Surgiphor vs Saline Joints

Unknown
NCT03618784Phase 1

Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis

Completed
NCT05112081Phase 4

Evaluation of Botox Treatment on Chronical Scrotal Pain

Not Yet Recruiting
NCT02947217Phase 4

Effect of Influenza Vaccination on IVF Outcomes - IVF

Unknown
NCT04260035Not Applicable

The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine Patients

Completed
NCT03640507Phase 2

Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline

Completed
NCT03204006Not Applicable

Attenuation of Hemodynamic Response to Laryngoscopy and Endotracheal Intubation With Single Dose of Dexmedetomidine in Hypertensive Patients.

Completed

Drug Details

Intervention Type
DRUG
Total Trials
38